Loading...
Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation
Peroxisome proliferator-activated receptor (PPAR) agonists have been suggested as novel therapeutics for the treatment of inflammatory lung disease, such as allergic asthma. Treatment with PPAR agonists has been shown to inhibit airway eosinophilia in murine models of allergic asthma, which can occu...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Science Inc
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4080964/ https://ncbi.nlm.nih.gov/pubmed/24628018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12280 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|